Muutke küpsiste eelistusi

E-raamat: Biomarkers in Liver Disease

Edited by , Edited by
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 555,74 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

With a focus on diseases of the liver, this work is part of a multi-volume Springer guide to biomarkers and their applications in various fields. It provides comprehensive coverage of biomarker applications in diagnosing and treating hepatic pathologies.



In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists.
Part I General Aspects and Introductory Material
1(264)
1 Traditional Markers in Liver Disease
3(20)
Giuseppe Derosa
Pamela Maffioli
2 Hepascore and Its Application to Liver Disease
23(24)
Yi Huang
Gary P. Jeffrey
Leon A. Adams
3 Model for End-Stage Liver Disease (MELD) Score as a Biomarker
47(24)
Deepika Devuni
Jawad Ahmad
4 Mechanistic Biomarkers in Liver Diseases
71(28)
Mitchell R. McGill
Benjamin L. Woolbright
James L. Weemhoff
Hartmut Jaeschke
5 Liver Transplantation Biomarkers in the Metabolomics Era
99(30)
Miriam Cortes
Juan Carlos Garcia-Cafiaveras
Eugenia Pareja
Agustin Lahoz
6 Liver Biomarkers and Their Applications to Nutritional Interventions in Animal Studies
129(24)
Cynthia Aparecida de Castro
Manoela Maciel dos Santos Dias
Karina Ana da Silva
Sandra Aparecida dos Reis
Lisiane Lopes da Conceicao
Leticia De Nadai Marcon
Luis Fernando de Sousa Moraes
Maria do Carmo Gouveia Peluzio
7 Serum Biomarkers for Evaluating Portal Hypertension
153(14)
Saad Elias
Barhoum Masad
Assy Nimer
8 Biomarkers for Recurrence of Hepatocellular Carcinoma
167(26)
Seow Chong Lee
Hwee Tong Tan
Maxey Ching Ming Chung
9 Biomarkers to Monitor Graft Function Following Liver Transplantation
193(28)
Cornelia J. Verhoeven
Luc J. W. van der Laan
Jeroen de Jonge
Herold J. Metselaar
10 Biomarkers of Extracellular Matrix Remodeling in Liver Diseases
221(26)
Mette J. Nielsen
Diana J. Leeming
Morten A. Karsdal
Aleksander Krag
11 Interaction of Sialyl transferases. Sialidases, and Sialic Acids in Liver Diseases and Applications to Biomarker Discovery
247(18)
A. Ata Alturfan
Ebru Emekli-Alturfan
Part II Body Fluids, Tissue, and Specific Biomarkers
265(372)
12 Biomarkers in Focus: Alanine Aminotransferase
267(14)
Guido Engelmann
13 Bilirubin as a Biomarker in Liver Disease
281(24)
Nahum Mendez-Sanchez
Libor Vitek
Nancy E. Aguilar-Olivos
Misael Uribe
14 AST-to-Platelet Ratio Index (APRI) as Marker in Liver Disease
305(16)
Agnieszka Bakula
Maciej Dadalski
15 Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease
321(28)
Holger Jon Moller
Konstantin Kazankov
Sidsel Rodgaard-Hansen
Marlene Christina Nielsen
Thomas D. Sandahl
Hendrik Vilstrup
Søren Kragh Moestrup
Henning Grenbak
16 CD133 and EpCAM as Biomarkers in Liver Diseases
349(24)
Anthony W. H. Chan
Ka-Fai To
17 Graft-Derived Cell-Free DNA as a Biomarker in Liver Transplantation
373(14)
Michael Oellerich
Ekkehard Schiitz
Julia Beck
Otto Kollmar
Philipp Kanzow
Anna Blum
Philip D. Walson
18 Cortisol as Biomarkers in Cirrhosis
387(20)
Luisa Spadaro
Graziella Privitera
Giuseppe Fede
Giovanni Meli
Francesco Purrello
19 Serum Sialic Acid as a Biomarker in Liver Disease
407(20)
Ewa Gruszewska
Lech Chrostek
20 Osteopontin as a Biomarker in Liver Disease
427(16)
Radan Bruha
21 Type VI Collagen: Biological Functions and Its Neo-epitope as Hepatic Fibrosis Biomarker
443(28)
Ki M. Mak
Chien Yi M. Png
22 Hydroxyproline as a Biomarker in Liver Disease
471(22)
Sami A. Gabr
Ahmad H. Alghadir
Yousery E. Sherif
Ayman A. Ghfar
23 Fibrinogen a-Chain as a Serum Marker of Liver Disease
493(20)
Santiago Maria
Wladimiro Jimenez
24 YKL-40 as a Biomarker of Liver Diseases
513(14)
Salvatore Musumeci
25 Phosphatidylethanol and Alcohol Use in Liver Disease Patients
527(18)
Scott H. Stewart
26 Circulating Extracellular Vesicles as Liver Biomarkers
545(14)
Qiang Shi
27 Squamous Cell Carcinoma Antigen-Immunoglobulin M (SCCA-IgM) as Biomarker in Liver Disease: Biological Aspects and Clinical Applications
559(22)
A. Biasiolo
A. Martini
A. Gallotta
G. Fassina
P. Pontisso
28 Peripheral Venous, Portal Venous, Hepatic Venous, and Arterial and Intrahepatic Cytokine Levels as Biomarkers and Functional Correlations
581(22)
Wim Verlinden
Sven Francque
Luisa Vonghia
29 Pentraxin 3 (PTX3) as a Biomarker of Liver Disease
603(20)
Bongkun Choi
Eun-Ju Chang
30 Alpha-Fetoprotein as a Biomarker in Hepatocellular Carcinoma: Focus on Its Role in Composition of Tumor Staging Systems and Monitoring of Treatment Response
623(14)
Stephen L. Chan
Anthony W. H. Chan
Simon C. H. Yu
Part III Genetic, Histological, Physical, and Imaging Methods
637(116)
31 Genetic Biomarkers of Paracetamol (Acetaminophen)-Induced Acute Liver Failure
639(28)
Michael H. Court
32 PNPLA3 Polymorphism and Nonalcoholic Fatty Liver Disease
667(26)
Olena Kolesnikova
Valeriya Nemtsova
Rajkumar Rajendram
33 Histological Biomarkers of Nonalcoholic Fatty Liver Disease
693(14)
Giuseppe Derosa
Pamela Maffioli
34 Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression in Liver Disease
707(12)
Giuseppe Derosa
Pamela Maffioli
35 Immunohistochemistry for Viral Hepatitis: Methods and Applications
719(16)
Cihan Yurdaydin
36 Phase Angle Bioelectrical Impedance Analysis (BIA) as a Biomarker Tool for Liver Disease
735(18)
Claudio Augusto Marroni
Daniella Miranda
Laura Boemeke
Sabrina Alves Fernandes
Part IV Specific Diseases and Conditions
753(244)
37 Biomarkers Associated with Adiposity and Metabolic Dysfunction in Hepatobiliary Tract Cancer
755(30)
Krasimira Aleksandrova
Sabrina Schlesinger
Marta Stelmach-Mardas
38 Biomarkers of the Antioxidant Response: A Focus on Liver Carcinogenesis
785(24)
Ricardo Sanchez-Rodriguez
Julia Esperanza Torres-Mena
Luis del Pozo Yauner
Julio Isael Perez-Carreon
39 microRNA-155 and microRNA-196b in Hepatitis C Virus Infection
809(28)
Ewelina Katuzna
40 Serum Alpha-Fetoprotein as a Biomarker in Liver Transplantation
837(34)
Samy Kashkoush
Sherif Saleh
Walid Elmoghazy
41 Immunological Biomarkers in Liver Transplantation
871(30)
Estela Solanas
Elena Martinez-Crespo
Alberto Lue
Pedro Baptista
M. Trinidad Serrano
42 Biomarkers for Hepatocellular Carcinoma in East Asia
901(26)
Peipei Song
Wei Tang
Norihiro Kokudo
43 Monocyte Chemotactic Protein-1 (Cytokine, Receptors, and Gene Polymorphisms) in Hepatitis
927(30)
Alicja E. Grzegorzewska
Adrianna Mostowska
44 Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals
957(20)
Arpita Basu
Paramita Basu
Timothy J. Lyons
45 Inflammatory Biomarkers in Ascites
977(20)
Philipp Lutz
Hans Dieter Nischalke
Ulrich Spengler
Part V Resources
997(10)
46 Recommended Resources on Biomarkers of Liver Diseases
999(8)
Rajkumar Rajendram
Vinood B. Patel
Victor R. Preedy
Index 1007
Professor Victor R. Preedy is a senior faculty member of King's College London (Professor of Nutritional Biochemistry) and King's College Hospital (Professor of Clinical Biochemistry). He is attached to both the Diabetes and Nutritional Sciences Division and the Department of Nutrition and Dietetics. He is also Director of the Genomics Centre and a member of the School of Medicine. Professor Preedy graduated in 1974 with an Honours Degree in Biology and Physiology with Pharmacology. He gained his University of London PhD in 1981. In 1993 he gained his second doctoral degree, for his outstanding contribution to protein metabolism in health and disease. He has received membership and fellowship of a number of academic and professional bodies in the UK, including the Royal College of Pathologists, the Royal Institute of Public Health, and the Royal Society of Chemistry. Professor Preedy has published over 570 articles, which includes 165 peer-reviewed manuscripts based on original research, 100 reviews, and over 50 books and book volumes.